Literature DB >> 7710358

A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells.

S Sabbioni1, M Negrini, P Rimessi, R Manservigi, G Barbanti-Brodano.   

Abstract

A BK virus (BKV) episomal vector (pRPneoCMV) was constructed for expression of cDNAs under control of the cytomegalovirus (CMV) immediate-early promoter. Transfection of pRPneoCMV for expression of the chloramphenicol acetyltransferase (CAT) gene in several human cell lines showed that the CMV promoter is more efficient than the HIV-1 and RSV LTRs in directing gene expression from episomal vectors. In 293 human cells pRPneoCMV/CAT is twenty times more active in CAT expression than the well known pSV2CAT vector in COS7 cells. Stable expression of the gene of the herpes simplex virus type 1 and type 2 glycoprotein G, cloned into pRPneoCMV, was obtained in 293 cells. This vector will allow direct cloning of newly synthesized cDNAs whose expression can be monitored in human cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710358     DOI: 10.1007/bf01309866

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  11 in total

1.  A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels.

Authors:  R C Switzer; C R Merril; S Shifrin
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

2.  DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons.

Authors:  D J McGeoch; H W Moss; D McNab; M C Frame
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

3.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

Authors:  M Boshart; F Weber; G Jahn; K Dorsch-Häsler; B Fleckenstein; W Schaffner
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

4.  Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1.

Authors:  M Ackermann; R Longnecker; B Roizman; L Pereira
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

5.  Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector.

Authors:  R Manservigi; M P Grossi; R Gualandri; P G Balboni; A Marchini; A Rotola; P Rimessi; D Di Luca; E Cassai; G Barbanti-Brodano
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  New BK virus episomal vector for complementary DNA expression in human cells.

Authors:  M P Grossi; A Caputo; P Rimessi; L Chiccoli; P G Balboni; G Barbanti-Brodano
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

7.  The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins.

Authors:  C M Gorman; D Gies; G McCray; M Huang
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

8.  BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli.

Authors:  G Milanesi; G Barbanti-Brodano; M Negrini; D Lee; A Corallini; A Caputo; M P Grossi; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

9.  High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.

Authors:  M Negrini; P Rimessi; S Sabbioni; A Caputo; P G Balboni; R Gualandri; R Manservigi; M P Grossi; G Barbanti-Brodano
Journal:  Biotechniques       Date:  1991-03       Impact factor: 1.993

10.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

View more
  1 in total

1.  Promoter type influences transcriptional topography by targeting genes to distinct nucleoplasmic sites.

Authors:  Joshua D Larkin; Argyris Papantonis; Peter R Cook
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.